ATXS - Astria Therapeutics, Inc. Stock Price, Fair Value and News

11.93USD-0.02 (-0.17%)Market Closed

Market Summary

USD11.93-0.02

Market Closed

-0.17%

ATXS Stock Price

View Fullscreen

ATXS RSI Chart

ATXS Valuation

Market Cap

655.1M

Price/Earnings (Trailing)

-8.03

Price/Free Cashflow

-8.82

ATXS Price/Earnings (Trailing)

ATXS Profitability

Return on Equity

-22.2%

Return on Assets

-21.55%

Free Cashflow Yield

-11.34%

ATXS Fundamentals

ATXS Earnings

Earnings (TTM)

-81.6M

Earnings Growth (Yr)

-78.12%

Earnings Growth (Qtr)

36.56%

Breaking Down ATXS Revenue

Last 7 days

6.5%

Last 30 days

32.7%

Last 90 days

32.6%

Trailing 12 Months

40.7%

How does ATXS drawdown profile look like?

ATXS Financial Health

Current Ratio

33.83

ATXS Investor Care

Shares Dilution (1Y)

95.94%

Diluted EPS (TTM)

-2.4

About Astria Therapeutics, Inc.

Astria Therapeutics, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of therapeutics for rare and niche allergic, and immunological diseases in the United States. Its lead product candidate is STAR-0215, a monoclonal antibody inhibitor of plasma kallikrein, which is in clinical development stage for the treatment of hereditary angioedema. The company was formerly known as Catabasis Pharmaceuticals, Inc. and changed its name to Astria Therapeutics, Inc. in September 2021. Astria Therapeutics, Inc. was incorporated in 2008 and is based in Boston, Massachusetts.

CEO	Ms. Jill C. Milne Ph.D.
WEBSITE	astriatx.com
INDUSTRY	Biotechnology
EMPLOYEES	45

Astria Therapeutics, Inc. Frequently Asked Questions

What is the ticker symbol for Astria Therapeutics, Inc.? What does ATXS stand for in stocks?

ATXS is the stock ticker symbol of Astria Therapeutics, Inc.. Every public company that trades on a stock exchange gets a ticker symbol.

What is the market capital of Astria Therapeutics, Inc. (ATXS)?

As of Fri Jul 26 2024, market cap of Astria Therapeutics, Inc. is 655.11 Million. The market capitalization is calculated by multiplying the stock price with the number of shares outstanding.

What is the fair value of ATXS stock?

You can check ATXS's fair value in chart for subscribers.

Is Astria Therapeutics, Inc. a good stock to buy?

The fair value guage provides a quick view whether ATXS is over valued or under valued. Whether Astria Therapeutics, Inc. is cheap or expensive depends on the assumptions which impact Astria Therapeutics, Inc.'s fair value. We provide several scenarios of inflation and growth to encompass these range of assumptions for ATXS.